Idenix Pharmaceuticals To Present at the Bear Stearns Biotech Confab and the Goldman Sachs 28th Annual Global Healthcare Confere
May 29 2007 - 8:30AM
PR Newswire (US)
CAMBRIDGE, Mass., May 29 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix
management will present a corporate overview at the upcoming Bear
Stearns Biotech Confab on Thursday, June 7th at 2:30 p.m. (EDT) in
Boston and at the Goldman Sachs 28th Annual Global Healthcare
Conference on Tuesday, June 12th at 11:00 a.m. (PDT) in Laguna
Niguel, CA. The live and archived webcasts of the presentations can
be accessed under "Calendar of Events" in the Idenix Investor
Center at http://www.idenix.com/. Please log in approximately 5-10
minutes before the events to ensure a timely connection. The
archived replays will be available on the Idenix website for two
weeks following the conferences. About Idenix Idenix
Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,
is a biopharmaceutical company engaged in the discovery,
development and commercialization of drugs for the treatment of
human viral and other infectious diseases. Idenix's current focus
is on the treatment of infections caused by hepatitis B virus,
hepatitis C virus and human immunodeficiency virus (HIV). For
further information about Idenix, please refer to
http://www.idenix.com/. DATASOURCE: Idenix Pharmaceuticals, Inc.
CONTACT: media, Teri Dahlman +1-617-995-9905, or investors, Amy
Sullivan, +1-617-995-9838, both of Idenix Pharmaceuticals, Inc. Web
site: http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals (MM) News Articles